Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness

被引:9
作者
Douma, WR
Kerstjens, HAM
Roos, CM
Koëter, GH
Postma, DS
机构
[1] Univ Groningen Hosp, Dept Pulmonol, NL-9713 GZ Groningen, Netherlands
[2] Univ Hosp Amsterdam, Dept Pulmonol, Amsterdam, Netherlands
关键词
asthma; bronchial hyperresponsiveness; peak expiratory flow;
D O I
10.1034/j.1399-3003.2000.16b07.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Guidelines for asthma management advocate home peak expiratory flow (PEF) monitoring. It is commonly stated that PEF variability is a good prosy of branchial hyperresponsiveness (BHR), a hallmark of asthma, However, this has hardly been tested longitudinally, as required to monitor asthma, This study assesses which PEF index correlates best with BHR longitudinally and whether the correlation improves when correcting PEF values for the known nonlinearity of mini-Wright PEF meters, Every 6 months, for a period of 2 yrs. PEF diary cards were filled in and BHR to histamine was tested in 104 patients with BHR and reversible airways obstruction, who started treatment with bronchodilators with (n=33) or without (n=71) inhaled corticosteroids, Within each subject, PEF indices and BHR were correlated longitudinally. The highest median correlation coefficients were obtained in the group of patients using inhaled corticosteroids. The PEF indices providing the best correlation with BHR were: mean PEF bronchodirator response (rho=-0.50) and within-day variation (% mean or % maximum) (with postbronchodilator values, rho=-0.50; without postbronchodilator values, rho=-0.40). Using PEF data corrected for the nonlinearity of the PEF meters did not result in higher correlation coefficients, Since current guidelines on asthma management recommend only bronchodilators on demand, the most useful peak expiratory flow index far reflecting bronchial hyperresponsiveness longitudinally is mean within-day peak expiratory flow variation (% mean or % maximum) (without postbronchodilator values). Since the correlation coefficients are not very strong, the authors suggest that peak expiratory now measurements are not used as a prosy for bronchial hyperresponsiveness longitudinally hut as a measurement in its own right. The use of corrections of peak expiratory flows far the nonlinearity of mini-Wright peak expiratory flow meters does not improve the correlation between peak expiratory flow and branchial hyperresponsiveness.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 20 条
[1]   INTERPRETATION OF BRONCHODILATOR RESPONSE IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE [J].
BRAND, PLP ;
QUANJER, PH ;
POSTMA, DS ;
KERSTJENS, HAM ;
KOETER, GH ;
DEKHUIJZEN, PNR ;
SLUITER, HJ .
THORAX, 1992, 47 (06) :429-436
[2]   INTERPRETATION OF SKIN-TESTS TO HOUSE DUST MITE AND RELATIONSHIP TO OTHER ALLERGY PARAMETERS IN PATIENTS WITH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BRAND, PLP ;
KERSTJENS, HAM ;
JANSEN, HM ;
KAUFFMAN, HF ;
DEMONCHY, JGR ;
KERREBIJN, KF ;
QUANJER, H ;
SLUITER, HJ ;
POUW, EM ;
SCHOONBROOD, DFME ;
ROOS, CM ;
DEGOOYER, A ;
POSTMA, DS ;
VANDERMARK, W ;
SLUITER, HJ ;
KOETER, GH ;
DEJONG, PM ;
STERK, PJ ;
WEVER, AMJ ;
DIJKMAN, JH ;
DEKHUIJZEN, PNR ;
FOLGERING, HTM ;
VANHERWAARDEN, CLA ;
OVERBEEK, SE ;
BOGAARD, JM ;
HILVERING, C ;
GANS, SJ ;
MENGELERS, HJJ ;
VANDERBRUGGEN, B ;
KREUKNIET, J ;
VANESSENZANDVLIET, EEM ;
KERREBIJN, KF ;
DUIVERMAN, EJ ;
KOUWENBERG, JM ;
PRINSEN, JE ;
WAALKENS, HJ ;
GERRITSEN, J ;
KNOL, K ;
KAPTEIN, AA ;
DEKKER, FW ;
MERKUS, PJFM ;
QUANJER, PH ;
POCOCK, SJ ;
HUGHES, MD ;
BLEECKER, ER ;
MEYERS, DA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (02) :560-570
[3]   BRONCHIAL REACTIVITY TO INHALED HISTAMINE - METHOD AND CLINICAL SURVEY [J].
COCKCROFT, DW ;
KILLIAN, DN ;
MELLON, JJA ;
HARGREAVE, FE .
CLINICAL ALLERGY, 1977, 7 (03) :235-243
[4]   THE ROLE OF THE PEAK FLOW METER IN THE DIAGNOSIS AND MANAGEMENT OF ASTHMA [J].
CROSS, D ;
NELSON, HS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 87 (01) :120-128
[5]   COMPARISON OF NORMAL AND ASTHMATIC CIRCADIAN-RHYTHMS IN PEAK EXPIRATORY FLOW-RATE [J].
HETZEL, MR ;
CLARK, TJH .
THORAX, 1980, 35 (10) :732-738
[6]   COMPARISON OF BRONCHIAL REACTIVITY AND PEAK EXPIRATORY FLOW VARIABILITY MEASUREMENTS FOR EPIDEMIOLOGIC STUDIES [J].
HIGGINS, BG ;
BRITTON, JR ;
CHINN, S ;
COOPER, S ;
BURNEY, PGJ ;
TATTERSFIELD, AE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03) :588-593
[7]   NONSPECIFIC BRONCHIAL REACTIVITY AND ITS RELATIONSHIP TO THE CLINICAL EXPRESSION OF ASTHMA - A LONGITUDINAL-STUDY [J].
JOSEPHS, LK ;
GREGG, I ;
MULLEE, MA ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :350-357
[8]   VARIABILITY OF BRONCHODILATOR RESPONSE AND EFFECTS OF INHALED CORTICOSTEROID TREATMENT IN OBSTRUCTIVE AIRWAYS DISEASE [J].
KERSTJENS, HAM ;
BRAND, PLP ;
QUANJER, PH ;
VANDERBRUGGENBOGAARTS, BAHA ;
KOETER, GH ;
POSTMA, DS .
THORAX, 1993, 48 (07) :722-729
[9]   A COMPARISON OF BRONCHODILATOR THERAPY WITH OR WITHOUT INHALED CORTICOSTEROID-THERAPY FOR OBSTRUCTIVE AIRWAYS DISEASE [J].
KERSTJENS, HAM ;
BRAND, PLP ;
HUGHES, MD ;
ROBINSON, NJ ;
POSTMA, DS ;
SLUITER, HJ ;
BLEECKER, ER ;
DEKHUIJZEN, PNR ;
DEJONG, PM ;
MENGELERS, HJJ ;
OVERBEEK, SE ;
SCHOONBROOD, DFME .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) :1413-1419
[10]   INFLUENCE OF TREATMENT ON PEAK EXPIRATORY FLOW ACID ITS RELATION TO AIRWAY HYPERRESPONSIVENESS AND SYMPTOMS [J].
KERSTJENS, HAM ;
BRAND, PLP ;
DEJONG, PM ;
KOETER, GH ;
POSTMA, DS ;
QUANJER, PH ;
SLUITER, HJ ;
POUW, EM ;
SCHOONBROOD, DFME ;
ROOS, CM ;
JANSEN, HM ;
DEGOOYER, A ;
VANDERMARK, TW ;
STERK, PJ ;
WEVER, AMJ ;
DIJKMAN, JH ;
DEKHUIJZEN, PNR ;
FOLGERING, HTM ;
VANHERWAARDEN, CLA ;
OVERBEEK, SE ;
BOGAARD, JM ;
HILVERING, C ;
GANS, SJ ;
MENGELERS, HJJ ;
VANDERBRUGGENBOGAARTS, BAHA ;
KREUKNIET, J ;
VANESSENZANDVLIET, EEM ;
KERREBIJN, KF ;
DUIVERMAN, EJ ;
KOUWENBERG, JM ;
PRINSEN, JE ;
WAALKENS, HJ ;
GERRITSEN, J ;
KNOL, K ;
DEMONCHY, JGR ;
DEKKER, FW ;
KAPTEIN, AA ;
MERKUS, PJFM ;
POCOCK, SJ ;
HUGHES, MD ;
BLEECKER, ER ;
MEYERS, DA .
THORAX, 1994, 49 (11) :1109-1115